Zhejiang Jingxin Pharmaceutical Co Ltd (002020):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zhejiang Jingxin Pharmaceutical Co Ltd (002020) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7620
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zhejiang Jingxin Pharmaceutical Co Ltd (Jingxin Pharma) is a pharmaceutical company that manufactures and markets traditional Chinese medicine. The company provides products such as finished dosage forms, Chinese herbal drugs and APIs. Its finished dosage products comprise simvastatin tablets, lovastatin capsules, fenofibrate capsules, gliclazid tablets, cilnidipine capsules, sertraline hydrochloride dispersing tablets, sertraline hydrochloride tablets, cisapride tablets, and ciprofloxacin hydrochloride capsules. Jingxin Pharma offers API products such as simvastatin, levofloxacin hemihydrate, ciprofloxacin hydrochloride, levofloxacin lactate, ofloxacin, enrofloxacin base, enrofloxaxin hydrochloride, ciprofloxacin lactate, and rosuvastatin calcium, among others. The company’s Chinese herbal drugs include coptis bolus ,mind-easing tonic, leucorrhea pill, sexoton pill, and menstruation-regulating bolus, and bolus for indigestion, among others. It offers its products in the dosage forms of tablets, capsules, large volume injections and powder for injections. Jingxin Pharma is headquartered in Shaoxing, China.

Zhejiang Jingxin Pharmaceutical Co Ltd (002020) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jingxin Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Zhejiang Jingxin Pharma and HYZ Healthcare Forms Joint Venture 12
Equity Offering 13
Zhejiang Jingxin Pharma Raises USD158.3 Million in Private Placement Shares 13
Mapi Pharma to Raise USD10 Million in Private Placement of Shares 14
Zhejiang Jingxin Pharma Announces Private Placement Of Shares For US$82 Million 15
Acquisition 16
Zhejiang Jingxin Pharma to Acquire 25% Stake in Spes Pharma for USD2 Million 16
Zhejiang Jingxin Pharma Plans to Acquire Additional 6.2% Stake in Pharmula Labs for USD0.5 Million 17
Zhejiang Jingxin Pharma to Acquire Stake in Pharma Two B for USD5 Million 18
Zhejiang Jingxin Pharma to Acquire 51% Stake in Pharmula Labs 19
Zhejiang Jingxin Pharmaceutical Co Ltd – Key Competitors 20
Zhejiang Jingxin Pharmaceutical Co Ltd – Key Employees 21
Zhejiang Jingxin Pharmaceutical Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jingxin Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jingxin Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Zhejiang Jingxin Pharma and HYZ Healthcare Forms Joint Venture 12
Zhejiang Jingxin Pharma Raises USD158.3 Million in Private Placement Shares 13
Mapi Pharma to Raise USD10 Million in Private Placement of Shares 14
Zhejiang Jingxin Pharma Announces Private Placement Of Shares For US$82 Million 15
Zhejiang Jingxin Pharma to Acquire 25% Stake in Spes Pharma for USD2 Million 16
Zhejiang Jingxin Pharma Plans to Acquire Additional 6.2% Stake in Pharmula Labs for USD0.5 Million 17
Zhejiang Jingxin Pharma to Acquire Stake in Pharma Two B for USD5 Million 18
Zhejiang Jingxin Pharma to Acquire 51% Stake in Pharmula Labs 19
Zhejiang Jingxin Pharmaceutical Co Ltd, Key Competitors 20
Zhejiang Jingxin Pharmaceutical Co Ltd, Key Employees 21
Zhejiang Jingxin Pharmaceutical Co Ltd, Subsidiaries 22

List of Figures
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jingxin Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Zhejiang Jingxin Pharmaceutical Co Ltd (002020):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stada Arzneimittel AG (SAZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of product …
  • Kaman Aerospace Group, Inc.:企業の戦略・SWOT・財務情報
    Kaman Aerospace Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kaman Aerospace Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Avesthagen Ltd-医療機器分野:企業M&A・提携分析
    Summary Avesthagen Ltd (Avesthagen) is a life science company that offers preventive personalized healthcare solutions. The company offers bio-nutrition, bio-agriculture and bio-pharmaceutical products. Its bio-nutrition products include validated bio-actives from Indian medicinal plants for prevent …
  • Builders FirstSource Inc:企業の戦略・SWOT・財務情報
    Builders FirstSource Inc - Strategy, SWOT and Corporate Finance Report Summary Builders FirstSource Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • Canadian Utilities Limited
    Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report Summary Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SEEK Limited:企業の戦略・SWOT・財務情報
    SEEK Limited - Strategy, SWOT and Corporate Finance Report Summary SEEK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • 23andMe Inc-医療機器分野:企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • Taikisha Ltd:企業の戦略・SWOT・財務分析
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Debiopharm Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Group (Debiopharm) is a biopharmaceutical company that develops biologics and small molecule drug candidates. The company’s product portfolio includes eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also of …
  • Frontage Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Frontage Laboratories Inc (Frontage), a subsidiary of Hangzhou Tigermed Consulting Co Ltd is a contract research organization that offers early phase drug development and other research services. The organization’s services include clinical research, drug metabolism and pharmacokinetic, CMC …
  • Diffusion Pharmaceuticals Inc (DFFN)-製薬・医療分野:企業M&A・提携分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standard-of-care therapies. The company offers new and small-molecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for life-threat …
  • Gulf Investment Corp:企業の戦略的SWOT分析
    Gulf Investment Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Tanfield Group PLC (TAN):企業の財務・戦略的SWOT分析
    Summary Tanfield Group plc (Tanfield Group) is an investment company that offers electrical investments. The company designs and produces electric commercial vehicles for short haul urban fleets. It also produces zero-emission vehicles that deliver better performance to traditional diesel trucks. Ta …
  • Equifax Inc.:企業の戦略・SWOT・財務情報
    Equifax Inc. - Strategy, SWOT and Corporate Finance Report Summary Equifax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Robert Half International Inc.:企業の戦略・SWOT・財務情報
    Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report Summary Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV) is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform …
  • Electricity Generating Authority of Thailand:企業の発電所・SWOT分析2018
    Electricity Generating Authority of Thailand - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Perpetual Energy Inc. (PMT)-石油・ガス分野:企業M&A・提携分析
    Summary Perpetual Energy Inc. (Perpetual Energy) is an exploration and production company. It explores, develops and produces from shallow gas, liquids-rich gas, heavy oil, bitumen and other assets. The company produces light and medium crude oil, heavy oil natural gas and natural gas liquids. Perpe …
  • Clevexel Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Clevexel Pharma SAS (Clevexel) is a pharmaceutical company that develops drugs for the treatment of central nervous system diseases. The company’s pipeline product candidate includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease pat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆